Alliancebernstein L.P. Amicus Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 369,229 shares of FOLD stock, worth $3.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

369,229

Previous 344,229 7.26%

Holding current value

$3.44 Million

Previous $3.41 Million 15.5%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $238,750 - $302,250	25,000 Added 7.26%	369,229 $3.94 Million
Q2 2024 Aug 14, 2024	BUY	$9.04 - $11.75 $197,704 - $256,972	21,870 Added 6.78%	344,229 $3.41 Million
Q1 2024 May 14, 2024	SELL	$11.43 - $14.24 $205,625 - $256,177	-17,990 Reduced 5.29%	322,359 $3.8 Million
Q4 2023 Feb 14, 2024	BUY	$9.97 - $14.52 $29,910 - $43,560	3,000 Added 0.89%	340,349 $4.83 Million
Q3 2023 Nov 14, 2023	SELL	$11.78 - $13.86 $353 - $415	-30 Reduced 0.01%	337,349 $4.1 Million
Q2 2023 Aug 15, 2023	BUY	$10.72 - $13.3 $229,622 - $284,886	21,420 Added 6.78%	337,379 $4.24 Million
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $327 - $406	30 Added 0.01%	315,959 $3.5 Million
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $11,868 - $15,240	1,200 Added 0.38%	315,929 $3.86 Million
Q3 2022 Nov 15, 2022	SELL	$9.82 - $12.75 $4.14 Million - $5.37 Million	-421,536 Reduced 57.25%	314,729 $3.29 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $339,036 - $605,150	54,420 Added 7.98%	736,265 $7.91 Million
Q1 2022 May 13, 2022	SELL	$7.89 - $12.48 $310,708 - $491,462	-39,380 Reduced 5.46%	681,845 $6.46 Million
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $171,093 - $216,742	-17,423 Reduced 2.36%	721,225 $8.33 Million
Q3 2021 Nov 10, 2021	BUY	$8.74 - $11.84 $3.14 Million - $4.25 Million	359,248 Added 94.69%	738,648 $7.05 Million
Q2 2021 Jul 30, 2021	SELL	$8.71 - $10.72 $32,227 - $39,664	-3,700 Reduced 0.97%	379,400 $3.66 Million
Q1 2021 May 06, 2021	SELL	$9.2 - $23.86 $1.3 Million - $3.37 Million	-141,266 Reduced 26.94%	383,100 $3.79 Million
Q3 2020 Nov 12, 2020	SELL	$12.89 - $15.89 $779,458 - $960,868	-60,470 Reduced 10.34%	524,366 $7.4 Million
Q2 2020 Aug 13, 2020	BUY	$8.86 - $15.69 $2.01 Million - $3.56 Million	226,800 Added 63.35%	584,836 $8.82 Million
Q1 2020 May 14, 2020	SELL	$6.63 - $11.16 $1.15 Million - $1.94 Million	-173,467 Reduced 32.64%	358,036 $3.31 Million
Q4 2019 Feb 18, 2020	BUY	$7.48 - $10.75 $1.58 Million - $2.27 Million	211,367 Added 66.02%	531,503 $5.18 Million
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $562,248 - $738,720	51,300 Added 19.08%	320,136 $4 Million
Q1 2019 May 14, 2019	SELL	$10.04 - $13.92 $2.47 Million - $3.42 Million	-246,000 Reduced 47.78%	268,836 $3.66 Million
Q4 2018 Feb 13, 2019	BUY	$8.38 - $13.44 $2.08 Million - $3.34 Million	248,500 Added 93.3%	514,836 $4.93 Million
Q2 2018 Aug 13, 2018	BUY	$13.13 - $17.09 $606,606 - $789,558	46,200 Added 20.99%	266,336 $4.16 Million
Q1 2018 May 14, 2018	SELL	$13.76 - $17.12 $505,129 - $628,475	-36,710 Reduced 14.29%	220,136 $3.31 Million
Q4 2017 Feb 13, 2018	SELL	$12.51 - $16.24 $1.01 Million - $1.32 Million	-80,980 Reduced 23.97%	256,846 $3.7 Million
Q3 2017 Nov 13, 2017	BUY	$11.74 - $15.78 $3.97 Million - $5.33 Million	337,826	337,826 $5.09 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.61B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Amicus Therapeutics, Inc. Transaction History